Relapses of CMV Retinitis After 2 Years of Highly Active Antiretroviral Therapy

British Journal of Ophthalmology- United Kingdom

doi 10.1136/bjo.84.10.1203

Full Text

Abstract

Available in

Categories

Molecular Neuroscience

Sensory Systems

Date

October 1, 2000

Authors

Publisher

BMJ

Related search

Cytomegalovirus Retinitis After the Initiation of Highly Active Antiretroviral Therapy: A 2 Year Prospective Study

British Journal of Ophthalmology

Molecular Neuroscience

Sensory Systems

English

HIV-related Morbidity Rate, Thirteen Years After the Introduction of Highly Active Antiretroviral Therapy (1996-2009)

Infectious Diseases

English

Ritonavir-Associated Toxicity Mimicking Retinitis Pigmentosa in an Hiv-Infected Patient on Highly Active Antiretroviral Therapy

Retinal Cases and Brief Reports

English

Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients With AIDS in the Era of Highly Active Antiretroviral Therapy

English

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

Molecular Biology

English

Progressive Neuropsychiatric Problems Following Institution of Highly Active Antiretroviral Therapy

Sexually Transmitted Infections

Infectious Diseases

English

Do All Patients With CMV Retinitis Require Life Long Anti-CMV Therapy?

British Journal of Ophthalmology

Molecular Neuroscience

Sensory Systems

English

Immune Reconstitution in HIV-1 Infected Patients Treated for Two Years With Highly Active Antiretroviral Therapy

Journal of Venomous Animals and Toxins Including Tropical Diseases

Infectious Diseases

English

Sclerosing Cholangitis by Cytomegalovirus in Highly Active Antiretroviral Therapy Era

Revista Espanola de Enfermedades Digestivas

Gastroenterology

English